Showing 49 to 60 of 80 results
Decreased Insurance Coverage for GLP-1 Agonists Amidst Soaring Demand
Between 2024 and 2025, insurance coverage for Ozempic dropped 22%, affecting 1.1 million people, while Zepbound saw a 14% increase in uninsured individuals (4.9 million), despite a 300% rise in Zepbound fills and doubled Ozempic fills since early 2024, highlighting the rising cost of these medicatio...
Decreased Insurance Coverage for GLP-1 Agonists Amidst Soaring Demand
Between 2024 and 2025, insurance coverage for Ozempic dropped 22%, affecting 1.1 million people, while Zepbound saw a 14% increase in uninsured individuals (4.9 million), despite a 300% rise in Zepbound fills and doubled Ozempic fills since early 2024, highlighting the rising cost of these medicatio...
Progress
36% Bias Score
Generic Ozempic Approaching Canada: Potential Cost Savings and Market Disruption
Generic versions of the blockbuster weight-loss drug Ozempic could be available in Canada as early as next year, potentially slashing costs by 65 percent and increasing patient access, based on applications from at least four companies; however, the impact on public drug plans remains unclear.
Generic Ozempic Approaching Canada: Potential Cost Savings and Market Disruption
Generic versions of the blockbuster weight-loss drug Ozempic could be available in Canada as early as next year, potentially slashing costs by 65 percent and increasing patient access, based on applications from at least four companies; however, the impact on public drug plans remains unclear.
Progress
44% Bias Score
Weight-Loss Jabs Show Promise in Reversing Liver Damage
Weight-loss injections, such as Ozempic and Wegovy, containing semaglutide, are showing promise in reversing severe liver damage caused by non-alcoholic fatty liver disease (NAFLD), according to a King's College London study; this offers hope for the millions of people who have this condition, cases...
Weight-Loss Jabs Show Promise in Reversing Liver Damage
Weight-loss injections, such as Ozempic and Wegovy, containing semaglutide, are showing promise in reversing severe liver damage caused by non-alcoholic fatty liver disease (NAFLD), according to a King's College London study; this offers hope for the millions of people who have this condition, cases...
Progress
56% Bias Score
German Chancellor's Culinary Confession and Roth's Age Misstatement Highlight Media Scrutiny
Die Aktuelle" published interviews with Chancellor Scholz, who humorously recounted the consequences of revealing his culinary skills, and Claudia Roth, who incorrectly stated her age relative to Friedrich Merz; other articles discussed Hollywood's use of Ozempic and family anecdotes from the Geiss ...
German Chancellor's Culinary Confession and Roth's Age Misstatement Highlight Media Scrutiny
Die Aktuelle" published interviews with Chancellor Scholz, who humorously recounted the consequences of revealing his culinary skills, and Claudia Roth, who incorrectly stated her age relative to Friedrich Merz; other articles discussed Hollywood's use of Ozempic and family anecdotes from the Geiss ...
Progress
56% Bias Score
GLP-1 Drug Adherence: Cost, Side Effects, and Income Disparities
A JAMA Network Open study reveals that 65% of patients without diabetes stopped using GLP-1 weight loss drugs within a year, compared to 46% of those with Type 2 diabetes; side effects and cost were the main reasons, while higher income and weight loss correlated with continued use; Noom's layoffs e...
GLP-1 Drug Adherence: Cost, Side Effects, and Income Disparities
A JAMA Network Open study reveals that 65% of patients without diabetes stopped using GLP-1 weight loss drugs within a year, compared to 46% of those with Type 2 diabetes; side effects and cost were the main reasons, while higher income and weight loss correlated with continued use; Noom's layoffs e...
Progress
40% Bias Score
Ozempic and Surgery: Increased Aspiration Risk
The U.K.'s MHRA warns that weight-loss drugs like Ozempic increase the risk of aspiration (stomach contents entering the lungs) during surgery due to slow gastric emptying, reporting a small number of cases, one resulting in aspiration pneumonia; patients should inform their healthcare providers.
Ozempic and Surgery: Increased Aspiration Risk
The U.K.'s MHRA warns that weight-loss drugs like Ozempic increase the risk of aspiration (stomach contents entering the lungs) during surgery due to slow gastric emptying, reporting a small number of cases, one resulting in aspiration pneumonia; patients should inform their healthcare providers.
Progress
52% Bias Score
High Cost of GLP-1 Weight Loss Drugs Limits Cost-Effectiveness
A JAMA Health Forum study found that despite improved health outcomes, GLP-1 weight loss medications like Wegovy and Zepbound are not currently cost-effective due to high net prices, patient non-persistence, and insurer churn; price reductions of 30% for tirzepatide and 82% for semaglutide are neede...
High Cost of GLP-1 Weight Loss Drugs Limits Cost-Effectiveness
A JAMA Health Forum study found that despite improved health outcomes, GLP-1 weight loss medications like Wegovy and Zepbound are not currently cost-effective due to high net prices, patient non-persistence, and insurer churn; price reductions of 30% for tirzepatide and 82% for semaglutide are neede...
Progress
56% Bias Score
Ozempic Shows Promise in Treating Alcohol Addiction
A new study published in JAMA Psychiatry shows that Semaglutid, the active ingredient in Ozempic, significantly reduced alcohol cravings and consumption in 48 participants with alcohol use disorder over nine weeks, suggesting a potential new treatment for alcohol addiction.
Ozempic Shows Promise in Treating Alcohol Addiction
A new study published in JAMA Psychiatry shows that Semaglutid, the active ingredient in Ozempic, significantly reduced alcohol cravings and consumption in 48 participants with alcohol use disorder over nine weeks, suggesting a potential new treatment for alcohol addiction.
Progress
40% Bias Score
80+ UK Deaths Linked to Weight-Loss Jabs
Over 80 Britons have died, and nearly 400 required hospitalization, after using weight-loss and diabetes jabs like Ozempic and Mounjaro, prompting calls for stricter regulations and raising concerns over the drugs' accessibility.
80+ UK Deaths Linked to Weight-Loss Jabs
Over 80 Britons have died, and nearly 400 required hospitalization, after using weight-loss and diabetes jabs like Ozempic and Mounjaro, prompting calls for stricter regulations and raising concerns over the drugs' accessibility.
Progress
64% Bias Score
Nurse on Trial for Fraudulent Use of Patient Details for Prescriptions
A County Down aesthetics nurse, Nichola Hawes, is on trial for allegedly using patients' details to prescribe medications like Ozempic and Botox without consent, following an investigation launched by the Medicines Regulatory Group in November 2022 after a potential breach in regulations was reporte...
Nurse on Trial for Fraudulent Use of Patient Details for Prescriptions
A County Down aesthetics nurse, Nichola Hawes, is on trial for allegedly using patients' details to prescribe medications like Ozempic and Botox without consent, following an investigation launched by the Medicines Regulatory Group in November 2022 after a potential breach in regulations was reporte...
Progress
32% Bias Score
Ozempic and Wegovy May Reduce Risk of Multiple Diseases: Large-Scale Study
A study of 1.2 million veterans' health records suggests that Ozempic and Wegovy, GLP-1 receptor agonists, may reduce risks of schizophrenia, Alzheimer's, and substance abuse, although further research is needed due to the study's limitations.
Ozempic and Wegovy May Reduce Risk of Multiple Diseases: Large-Scale Study
A study of 1.2 million veterans' health records suggests that Ozempic and Wegovy, GLP-1 receptor agonists, may reduce risks of schizophrenia, Alzheimer's, and substance abuse, although further research is needed due to the study's limitations.
Progress
52% Bias Score
Fat Cell Memory Explains Weight Regain After Dieting
A Nature study reveals that fat cells 'remember' being fat, making weight loss difficult; 90% of dieters regain weight due to epigenetic changes in fat cells that persist even after weight loss, highlighting the need for long-term lifestyle changes for sustainable weight management.
Fat Cell Memory Explains Weight Regain After Dieting
A Nature study reveals that fat cells 'remember' being fat, making weight loss difficult; 90% of dieters regain weight due to epigenetic changes in fat cells that persist even after weight loss, highlighting the need for long-term lifestyle changes for sustainable weight management.
Progress
40% Bias Score
Showing 49 to 60 of 80 results